Cargando…
Antibody-mediated blockade of phosphatidylserine enhances the anti-tumor activity of targeted therapy and immune checkpoint inhibitors by affecting myeloid and lymphocyte populations in the tumor microenvironment
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292574/ http://dx.doi.org/10.1186/2051-1426-2-S3-P266 |
| _version_ | 1782352503172497408 |
|---|---|
| author | Yopp, Adam Kallinteris, Nikoletta Huang, Xianming Shan, Joe Menander, Kerstin Freimark, Bruce Hutchins, Jeff King, Steve Gabrilovich, Dmitry I Brekken, Rolf |
| author_facet | Yopp, Adam Kallinteris, Nikoletta Huang, Xianming Shan, Joe Menander, Kerstin Freimark, Bruce Hutchins, Jeff King, Steve Gabrilovich, Dmitry I Brekken, Rolf |
| author_sort | Yopp, Adam |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4292574 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42925742015-01-15 Antibody-mediated blockade of phosphatidylserine enhances the anti-tumor activity of targeted therapy and immune checkpoint inhibitors by affecting myeloid and lymphocyte populations in the tumor microenvironment Yopp, Adam Kallinteris, Nikoletta Huang, Xianming Shan, Joe Menander, Kerstin Freimark, Bruce Hutchins, Jeff King, Steve Gabrilovich, Dmitry I Brekken, Rolf J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4292574/ http://dx.doi.org/10.1186/2051-1426-2-S3-P266 Text en Copyright © 2014 Yopp et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Yopp, Adam Kallinteris, Nikoletta Huang, Xianming Shan, Joe Menander, Kerstin Freimark, Bruce Hutchins, Jeff King, Steve Gabrilovich, Dmitry I Brekken, Rolf Antibody-mediated blockade of phosphatidylserine enhances the anti-tumor activity of targeted therapy and immune checkpoint inhibitors by affecting myeloid and lymphocyte populations in the tumor microenvironment |
| title | Antibody-mediated blockade of phosphatidylserine enhances the anti-tumor activity of targeted therapy and immune checkpoint inhibitors by affecting myeloid and lymphocyte populations in the tumor microenvironment |
| title_full | Antibody-mediated blockade of phosphatidylserine enhances the anti-tumor activity of targeted therapy and immune checkpoint inhibitors by affecting myeloid and lymphocyte populations in the tumor microenvironment |
| title_fullStr | Antibody-mediated blockade of phosphatidylserine enhances the anti-tumor activity of targeted therapy and immune checkpoint inhibitors by affecting myeloid and lymphocyte populations in the tumor microenvironment |
| title_full_unstemmed | Antibody-mediated blockade of phosphatidylserine enhances the anti-tumor activity of targeted therapy and immune checkpoint inhibitors by affecting myeloid and lymphocyte populations in the tumor microenvironment |
| title_short | Antibody-mediated blockade of phosphatidylserine enhances the anti-tumor activity of targeted therapy and immune checkpoint inhibitors by affecting myeloid and lymphocyte populations in the tumor microenvironment |
| title_sort | antibody-mediated blockade of phosphatidylserine enhances the anti-tumor activity of targeted therapy and immune checkpoint inhibitors by affecting myeloid and lymphocyte populations in the tumor microenvironment |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292574/ http://dx.doi.org/10.1186/2051-1426-2-S3-P266 |
| work_keys_str_mv | AT yoppadam antibodymediatedblockadeofphosphatidylserineenhancestheantitumoractivityoftargetedtherapyandimmunecheckpointinhibitorsbyaffectingmyeloidandlymphocytepopulationsinthetumormicroenvironment AT kallinterisnikoletta antibodymediatedblockadeofphosphatidylserineenhancestheantitumoractivityoftargetedtherapyandimmunecheckpointinhibitorsbyaffectingmyeloidandlymphocytepopulationsinthetumormicroenvironment AT huangxianming antibodymediatedblockadeofphosphatidylserineenhancestheantitumoractivityoftargetedtherapyandimmunecheckpointinhibitorsbyaffectingmyeloidandlymphocytepopulationsinthetumormicroenvironment AT shanjoe antibodymediatedblockadeofphosphatidylserineenhancestheantitumoractivityoftargetedtherapyandimmunecheckpointinhibitorsbyaffectingmyeloidandlymphocytepopulationsinthetumormicroenvironment AT menanderkerstin antibodymediatedblockadeofphosphatidylserineenhancestheantitumoractivityoftargetedtherapyandimmunecheckpointinhibitorsbyaffectingmyeloidandlymphocytepopulationsinthetumormicroenvironment AT freimarkbruce antibodymediatedblockadeofphosphatidylserineenhancestheantitumoractivityoftargetedtherapyandimmunecheckpointinhibitorsbyaffectingmyeloidandlymphocytepopulationsinthetumormicroenvironment AT hutchinsjeff antibodymediatedblockadeofphosphatidylserineenhancestheantitumoractivityoftargetedtherapyandimmunecheckpointinhibitorsbyaffectingmyeloidandlymphocytepopulationsinthetumormicroenvironment AT kingsteve antibodymediatedblockadeofphosphatidylserineenhancestheantitumoractivityoftargetedtherapyandimmunecheckpointinhibitorsbyaffectingmyeloidandlymphocytepopulationsinthetumormicroenvironment AT gabrilovichdmitryi antibodymediatedblockadeofphosphatidylserineenhancestheantitumoractivityoftargetedtherapyandimmunecheckpointinhibitorsbyaffectingmyeloidandlymphocytepopulationsinthetumormicroenvironment AT brekkenrolf antibodymediatedblockadeofphosphatidylserineenhancestheantitumoractivityoftargetedtherapyandimmunecheckpointinhibitorsbyaffectingmyeloidandlymphocytepopulationsinthetumormicroenvironment |